Investing in biotech stocks isn't for everyone. An unsuccessful clinical trial can cause a huge decline. The competition is ...
Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...
Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in ...